ghk-cu clinical trials safety Frontiers ghk-cu clinical trials safety efficacy

BPC-157 Standalone Targeted tissue repair and inflammation support A synthetic peptide derived from a naturally occurring protein, BPC-157 promotes angiogenesis, improves blood flow to damaged areas, and supports healing across musculoskeletal and gastrointestinal systems at the cellular level

The Structural Studies Alongside the clinical program, structural biology has begun to explain how amylin-class peptides engage their receptor targets

BPC-157 ist ein Pentadecapeptid (15 AA, Sequenz: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) mit der Summenformel C 62 H 98 N 16 O 22 und einem MW von 1419.53 g/mol (CAS: 137525-51-0)

Cui X, Wakai T, Shirai Y, Hatakeyama K, Hirano S